Antonella Di Pasquale

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity

Antonella Di Pasquale, Stefania Morino, Simona Loreti et al. · Neurology · 2015 · 107 citations

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Hypogonadism in DM1 and its relationship to erectile dysfunction

Giovanni Antonini, Alessandro Clemenzi, Elisabetta Bucci et al. · Journal of Neurology · 2011 · 24 citations

Infertility, Urology, Andrology +5

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text